Senior Vice President, Chief Medical Officer · Celldex Therapeutics, Inc. (CLDX)

Diane Young

A named executive officer of Celldex Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$2,966,205

Salary $461,848Stock awards $0Bonus $228,000

FY2022: $1,939,221

3rd of 5 named executive officers at Celldex Therapeutics by FY2023 total.

5 named officers on file for Celldex Therapeutics, FY2023

Diane Young’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • CLDX’s disclosed peer group of 24 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Celldex Therapeutics’s whole pay program stands against its peers

  • Celldex Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Diane Young’s full pay file as a PDF — free

More than this page: up to 10 years of Diane’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Diane Young compensation by year

Celldex Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Celldex Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$430,163$445,219$461,848
Bonus$200,000$192,274$228,000
Stock awards$0$0$0
Option awards$1,564,970$1,295,724$2,269,752
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$5,834$6,004$6,605
Total$2,200,967$1,939,221$2,966,205

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Celldex Therapeutics, Inc. DEF 14A filed April 25, 2024, accession 0001104659-24-051634, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Celldex Therapeutics, Inc. filed document, accession 0001104659-24-051634. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.

$2.2M
$1.9M
$3.0M
FY21
FY22
FY23
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
Option80,000—$36.87
Option47,500—$22.48
Option27,000—$28.00
Option9,000—$10.38

Per the Outstanding Equity Awards at Fiscal Year-End table in Celldex Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

6 Form 4 lines since the FY2023 proxy (filed April 25, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-06-25Grant or award derivative—57,000$0.0057,000
2025-06-05Grant or award derivative—72,000$0.0072,000
2024-06-13Grant or award derivative—72,000$0.0072,000
2024-06-11Exercise or conversion—15,000$2.7117,115
2024-06-11Exercise or conversion derivative—15,000$0.000
2024-06-07Sale—45,000$35.262,115

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Celldex Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Anthony MarucciPresident and Chief Executive Officer$8,361,844
Tibor KelerExecutive Vice President and Chief Scientific Officer$3,420,609
Diane Young · this pageSenior Vice President, Chief Medical Officer$2,966,205
Sam MartinSenior Vice President and Chief Financial Officer$2,946,626
Margo Heath-ChiozziSenior Vice President, Regulatory Affairs$2,936,966

Board service

Celldex Therapeutics board · FY2023

How this board is paid

Company policy: Celldex Therapeutics pays directors a $43,200 cash retainer. As stated in Celldex Therapeutics's FY2023 proxy.

The full Celldex Therapeutics compensation record

free company brief

This page is one person within Celldex Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Celldex Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Celldex Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Diane Young's compensation dossier · One-time report. No refunds.